Last reviewed · How we verify
Corticosteroid or NSAID — Competitive Intelligence Brief
marketed
Corticosteroid or NSAID
Immunology, Rheumatology, Pain Management
Small molecule
Live · refreshed every 30 min
Target snapshot
Corticosteroid or NSAID (Corticosteroid or NSAID) — Hoffmann-La Roche. Corticosteroids suppress immune and inflammatory responses by binding glucocorticoid receptors, while NSAIDs inhibit cyclooxygenase enzymes to reduce prostaglandin production and inflammation.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Corticosteroid or NSAID TARGET | Corticosteroid or NSAID | Hoffmann-La Roche | marketed | Corticosteroid or NSAID |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Corticosteroid or NSAID class)
- Hoffmann-La Roche · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Corticosteroid or NSAID CI watch — RSS
- Corticosteroid or NSAID CI watch — Atom
- Corticosteroid or NSAID CI watch — JSON
- Corticosteroid or NSAID alone — RSS
- Whole Corticosteroid or NSAID class — RSS
Cite this brief
Drug Landscape (2026). Corticosteroid or NSAID — Competitive Intelligence Brief. https://druglandscape.com/ci/corticosteroid-or-nsaid. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing